One study using AD patient-derived 2D cultures found treatment with β-secretase inhibitors showed significant reduction in hyperphosphorylated tau and active glycogen synthase kinase-3β in neurons (Israel et al., 2012). The gene discussed is MAPT; the disease is Alzheimer disease.